Peter Lynch's Advice: 'Growth Stocks Are Better Than Nongrowth Stocks'
Peter Lynch zeroes in on sales-driven growth stocks amidst a scarcity in the market. Lynch challenges investors to pivot to turnarounds and special situations when growth is sparse. Volatility can create massive trading opportunities-if you know how to capitalize on it.
Nvidia CEO Jensen Huang's Joke Sparks Concerns Over Rapid Depreciation Of AI Chips
Nvidia CEO's offhand joke stirs unease over the lifespan and relevance of AI hardware investments. Cloud giants face potential billion-dollar hits to operating income due to rapid tech depreciation. Pelosi's latest AI pick skyrocketed 169% in just one month.
Prediction: Oracle Stock Could Surge by 200% in the Next 5 Years
Oracle ( NYSE: ORCL ) has been a steady performer on the stock market over the past five years, delivering respectable gains of 230% to investors and outperforming the Nasdaq Composite's 143% jump by a handsome margin. But the technology giant has been under pressure this year.Shares of the ...
ARNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Arconic Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, March 23, 2025 ( GLOBE NEWSWIRE ) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Arconic Corporation ( "Arconic" or "the Company" ) ARNC and certain of its officers.
MODV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ModivCare, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ModivCare ( NASDAQ:MODV )
NEW YORK, March 23, 2025 ( GLOBE NEWSWIRE ) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ModivCare, Inc. ( "ModivCare" or "the Company" ) MODV and certain of its officers.
GO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Grocery Outlet Holding Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Grocery Outlet Holding ( NASDAQ:GO )
NEW YORK, March 23, 2025 ( GLOBE NEWSWIRE ) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Grocery Outlet Holding Corp. ( "Grocery Outlet" or "the Company" ) GO and certain of ...
IAS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Integral Ad Science Holding Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Integral Ad Science Holdi ( NASDAQ:IAS )
NEW YORK, March 23, 2025 ( GLOBE NEWSWIRE ) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Integral Ad Science Holding Corp. ( "IAS" or "the Company" ) IAS and certain of its ...
UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema ( DME ) on March 24, 2025 - Unity Biotechnology ( NASDAQ:UBX )
SOUTH SAN FRANCISCO, Calif., March 23, 2025 ( GLOBE NEWSWIRE ) -- UNITY Biotechnology, Inc. ( "UNITY" ) UBX, a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that it will host a virtual investor event on Monday, March 24, 2025, at 8:00 ...
EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ESSA Pharma ( NASDAQ:EPIX )
NEW YORK, March 23, 2025 ( GLOBE NEWSWIRE ) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ESSA Pharma Inc. ( "ESSA" or "the Company" ) EPIX and certain of its officers.
UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema ( DME ) on March 24, 2025
SOUTH SAN FRANCISCO, Calif., March 23, 2025 ( GLOBE NEWSWIRE ) -- UNITY Biotechnology, Inc. ( "UNITY" ) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that it will host a virtual investor event on Monday, March 24, ...